Squawk on the Street

The opening hour of CNBC’s "Squawk on the Street" with Carl Quintanilla, Jim Cramer and David Faber is broadcast each weekday from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for inform...

The opening hour of CNBC’s "Squawk on the Street" with Carl Quintanilla, Jim Cramer and David Faber is broadcast each weekday from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for inform...

The opening hour of CNBC’s "Squawk on the Street" with Carl Quintanilla, Jim Cramer and David Faber is broadcast each weekday from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for inform...

Carl Quintanilla, Jon Fortt and Leslie Picker led off with the big story of the morning: Alibaba shares tumbling on news that the e-commerce giant founded by Jack Ma is the target of a newly launched antitrust investigation by the Chinese government. They also discussed the House Democrats' push to approve $2,000 pandemic aid checks, which failed after Republican lawmakers blocked the unanimous co...

Carl Quintanilla, Morgan Brennan and Mike Santoli discussed Pfizer and BioNTech announcing that they've struck an agreement with the US government to supply an additional 100 million doses of their COVID-19 vaccine. The anchors also took a closer look at market reaction to President Trump's criticism of the $900-billion pandemic aid package -- and his demand that direct payments for individuals sh...

Carl Quintanilla, Jim Cramer and David Faber discussed the surge in Apple shares, extending their gains from Monday on a report that the company plans to enter the electric car market in 2024. The anchors explored what such a development could mean for Tesla. They also discussed what's next for stocks one day after the Dow closed with a gain after erasing a 423-point loss. Also in focus: Google an...

Carl Quintanilla, Jim Cramer and David Faber discussed a rough morning for stocks: Markets reacting to news of a new strain of the coronavirus resulting in lockdowns throughout the UK, as well as travel restrictions to and from that country. Travel-related stocks taking a hit on those developments, which overshadowed two major stories: Capitol Hill lawmakers reaching an agreement on the $900-billi...

Jim Cramer and David Faber discussed another historic day for stocks as all three major indices set fresh record highs. They explored high-flying names such as Tesla, which will open trading on Monday as a new member of the S&P 500. Jim and David also interviewed the CEO of cybersecurity company Palo Alto Networks, discussing the suspected Russian hack and how it could be far worse than feared. Al...

Jim Cramer and David Faber discussed a strong morning for stocks which saw the S&P 500 and Nasdaq hit fresh record highs, helped by hopes Capitol Hill lawmakers will soon strike a deal on pandemic aid relief. Also, an FDA panel expected to approve Moderna’s COVID-19 vaccine for emergency use. Jim and David reacted to Dr. Anthony Fauci’s comments at the CNBC “Healthy Returns” conference, talking ab...

Carl Quintanilla, Jim Cramer and David Faber stayed on top of developments in Washington, where Capitol Hill lawmakers are trying to strike a deal on a COVID-19 relief package. The anchors also explored the Nasdaq’s record run and its disconnect from how small businesses and others have been struggling during the pandemic. Carl, Jim and David reacted to what HHS Secretary Alex Azar told CNBC about...

One day after the Dow hit an intraday record high and the S&P 500 extended its daily losing streak to four, Carl Quintanilla, Jim Cramer and David Faber discussed how stocks are reacting to the latest developments surrounding COVID-19 vaccines on the second day of an historic rollout in the U.S. Also, the FDA saying it finds Moderna’s vaccine to be almost 95% effective. The anchors also took a clo...

Carl Quintanilla, Jim Cramer and David Faber led off the program by discussing the start of the largest vaccination campaign in U.S. history as health care workers began receiving Pfizer-BioNTech's COVID-19 vaccine after the FDA authorized it for emergency use. News of the vaccine rollout and optimism surrounding stimulus talks resulting in a strong start for stocks. The anchors also discussed the...

Carl Quintanilla, Jim Cramer and David Faber discussed the pullback in markets as worries about an impasse in stimulus talks overshadowed some of the positive news on COVID-19 vaccines. They also took a closer look at Disney: Shares up sharply one day after the company outlined its streaming strategy at its Investor Day event. Also in focus: Airbnb the morning after its blockbuster trading debut w...

Carl Quintanilla, Jim Cramer and David Faber led off the show by discussing Airbnb’s long-awaited public debut one day after DoorDash soared 85% on its first day for trading. Airbnb Co-Founder & CEO Brian Chesky joined the program in a live interview and spoke about everything from its IPO to the state of the travel industry and how his company is faring amid the pandemic. Carl, Jim and David also...

Carl Quintanilla, Jim Cramer and David Faber led off the program by drilling down on DoorDash's much-anticipated IPO, which priced at $102 per share -- above the expected range. They also spoke with DoorDash Co-Founder & CEO Tony Xu, discussing everything from the IPO to the future of the food delivery company and how it's handling the pandemic. Delta Air Lines CEO Ed Bastian also joined the progr...

Carl Quintanilla, Jim Cramer and David Faber discussed major developments regarding COVID-19 vaccines and what they could mean for the markets: The FDA said data from Pfizer’s vaccine trials were "consistent" with recommendations put forth by the agency for an emergency use authorization. Also, The UK has begun vaccinating its citizens in an effort to combat the virus. The anchors reacted to Pfize...

After a week which ended with stocks hitting all-time highs, Carl Quintanilla, Jim Cramer and David Faber discuss what's next for the markets what's been driving the record run: Good stories from multinational companies, COVID-19 vaccine hopes acting as a "stimulus" for the markets, plus young investors seeing beaten-down shares in the travel industry and others as buying opportunities. The anchor...

Carl Quintanilla, Jim Cramer and David Faber reacted to the November jobs report and explored what the results could mean for stimulus talks and the potential passage of a pandemic relief package. National Economic Council Director Larry Kudlow joined the program and offered White House reaction to the jobs numbers as well as his perspective on relief aid. As COVID-19 cases continue to surge, the...

Carl Quintanilla, Jim Cramer and David Faber discussed Wall Street's hopes for passage of a pandemic relief bill: Democratic leaders on Capitol Hill signaled that a $908-billion bipartisan proposal would be a starting point for negotiations with the White House and Republican leaders. This in wake of COVID-19 cases and deaths in the U.S. set one-day records on Wednesday. The pandemic's impact also...

One day after the S&P 500 and Nasdaq rallied to record closing highs, Carl Quintanilla, Jim Cramer and David Faber discussed The U.K. authorizing Pfizer-BioNTech's COVID-19 vaccine for emergency use. The anchors reacted to Treasury Secretary-Designate Janet Yellen's comments about the urgency of getting pandemic relief for Americans as the Washington stalemate on stimulus continues. Carl, Jim and...

On the first trading day of December, Carl Quintanilla, Jim Cramer and David Faber explored what's next for stocks after November's rally, which marked the Dow's best month since 1987 and the best monthly performance for the S&P 500 and Nasdaq since April of this year. The anchors also previewed what to expect from Fed Chair Powell and Treasury Secretary Mnuchin ahead of their testimony at a Senat...

On the final trading day of what has been a strong November for stocks, Carl Quintanilla, Jim Cramer and David Faber discussed the latest vaccine developments from Moderna: The company's shares surging on new data showing its COVID-19 vaccine candidate is more than 94-percent effective and was safe. Moderna also says it will ask the FDA to authorize the vaccine for emergency use. On the M&A front:...

David Faber, Melissa Lee and Mike Santoli discussed the road ahead for stocks on the final trading day of a week that has seen record highs, adding to a red-hot November for the markets. They also reacted to President Trump saying he’d commit to conceding the election if the electoral college calls the race for President-elect Biden. The anchors also explored what to expect from retail stocks on t...

One day after the Dow closed above 30,000 for the first time ever, Carl Quintanilla, David Faber and Mike Santoli discussed the red-hot November rally and how much upward momentum is in store for stocks, including the surge in electric vehicle names such as Tesla and Nikola. As for COVID-19, the anchors reacted to what President-Elect Biden told NBC Nightly News anchor Lester Holt about vaccine di...

Carl Quintanilla, Jim Cramer and David Faber discussed the rally for stocks on this first trading day since the Trump Administration officially authorized the Biden presidential transition. With President-Elect Biden expected to nominate former Fed Chair Janet Yellen as his Treasury Secretary, the anchors took a closer look at what such a decision could mean for the markets. They also explored a q...